180 related articles for article (PubMed ID: 21816639)
21. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
22. A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy.
Hu Y; Ahmed HU; Carter T; Arumainayagam N; Lecornet E; Barzell W; Freeman A; Nevoux P; Hawkes DJ; Villers A; Emberton M; Barratt DC
BJU Int; 2012 Sep; 110(6):812-20. PubMed ID: 22394583
[TBL] [Abstract][Full Text] [Related]
23. [Transrectal ultrasound-guided prostatic biopsy: contribution of an ultrasound diagnostic unit after ten years of experience].
Rodríguez-Patrón Rodríguez R; Mayayo Dehesa T; García González R; Arias Fúnez F; Lennie Zuccarino A; Sanz Mayayo E
Arch Esp Urol; 2006 May; 59(4):397-406. PubMed ID: 16800137
[TBL] [Abstract][Full Text] [Related]
24. MRI-Based Prostate-Specific Antigen Density Predicts Gleason Score Upgrade in an Active Surveillance Cohort.
Washington SL; Baskin AS; Ameli N; Nguyen HG; Westphalen AC; Shinohara K; Carroll PR
AJR Am J Roentgenol; 2020 Mar; 214(3):574-578. PubMed ID: 31913068
[No Abstract] [Full Text] [Related]
25. Clinical significance of repeat sextant biopsies in prostate cancer patients.
Stroumbakis N; Cookson MS; Reuter VE; Fair WR
Urology; 1997 Mar; 49(3A Suppl):113-8. PubMed ID: 9123730
[TBL] [Abstract][Full Text] [Related]
26. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
Park SJ; Miyake H; Hara I; Eto H
Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
[TBL] [Abstract][Full Text] [Related]
27. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.
Walton Diaz A; Shakir NA; George AK; Rais-Bahrami S; Turkbey B; Rothwax JT; Stamatakis L; Hong CW; Siddiqui MM; Okoro C; Raskolnikov D; Su D; Shih J; Han H; Parnes HL; Merino MJ; Simon RM; Wood BJ; Choyke PL; Pinto PA
Urol Oncol; 2015 May; 33(5):202.e1-202.e7. PubMed ID: 25754621
[TBL] [Abstract][Full Text] [Related]
28. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
[TBL] [Abstract][Full Text] [Related]
29. Robot-assisted laparoscopic radical prostatectomy in patients with prostate cancer with high-risk features: predictors of favorable pathologic outcome.
Uberoi J; Brison D; Patel N; Sawczuk IS; Munver R
J Endourol; 2010 Mar; 24(3):403-7. PubMed ID: 20078237
[TBL] [Abstract][Full Text] [Related]
30. Refining the risk-stratification of transrectal biopsy-detected prostate cancer by elastic fusion registration transperineal biopsies.
Covin B; Roumiguié M; Quintyn-Ranty ML; Graff P; Khalifa J; Aziza R; Ploussard G; Portalez D; Malavaud B
World J Urol; 2019 Feb; 37(2):269-275. PubMed ID: 30145777
[TBL] [Abstract][Full Text] [Related]
31. A Nationwide Analysis of Risk of Prostate Cancer Diagnosis and Mortality following an Initial Negative Transrectal Ultrasound Biopsy with Long-Term Followup.
Kawa SM; Stroomberg HV; Larsen SB; Helgstrand JT; Toft BG; Vickers AJ; Brasso K; Røder MA
J Urol; 2022 Jul; 208(1):100-108. PubMed ID: 35212571
[TBL] [Abstract][Full Text] [Related]
32. The implication of initial 24-core transrectal prostate biopsy protocol on the detection of significant prostate cancer and high grade prostatic intraepithelial neoplasia.
Nomikos M; Karyotis I; Phillipou P; Constadinides C; Delakas D
Int Braz J Urol; 2011; 37(1):87-93; discussion 93. PubMed ID: 21385484
[TBL] [Abstract][Full Text] [Related]
33. Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.
Merrick GS; Delatore A; Butler WM; Bennett A; Fiano R; Anderson R; Adamovich E
Am J Clin Oncol; 2017 Feb; 40(1):53-59. PubMed ID: 25068472
[TBL] [Abstract][Full Text] [Related]
34. [The significance of rebiopsy in the diagnosis of prostate cancer].
Braun KP; Brookman-Amissah S; May M; Grassmel Y; Heintze C; Hoschke B; Braun V
Urologe A; 2009 Feb; 48(2):163-9. PubMed ID: 18797836
[TBL] [Abstract][Full Text] [Related]
35. Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
Al Otaibi M; Ross P; Fahmy N; Jeyaganth S; Trottier H; Sircar K; Bégin LR; Souhami L; Kassouf W; Aprikian A; Tanguay S
Cancer; 2008 Jul; 113(2):286-92. PubMed ID: 18484590
[TBL] [Abstract][Full Text] [Related]
36. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
[TBL] [Abstract][Full Text] [Related]
37. Important preoperative prognostic factors for extracapsular extension, seminal vesicle invasion and lymph node involvement in cases with radical retropubic prostatectomy.
Ozgür A; Onol FF; Türkeri LN
Int Urol Nephrol; 2004; 36(3):369-73. PubMed ID: 15783108
[TBL] [Abstract][Full Text] [Related]
38. Optimization of prostate biopsy in patients considered for active surveillance. The role of the confirmatory biopsy and transperineal techniques.
Fernandez Gomez JM; Garcia Rodriguez J
Arch Esp Urol; 2014 Jun; 67(5):409-18. PubMed ID: 24914840
[TBL] [Abstract][Full Text] [Related]
39. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
[TBL] [Abstract][Full Text] [Related]
40. Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
Pepe P; Garufi A; Priolo G; Pennisi M
World J Urol; 2016 Sep; 34(9):1249-53. PubMed ID: 26699628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
